PainReform ( (PRFX) ) just unveiled an announcement.
On February 27, 2025, PainReform Ltd. announced it will hold an Extraordinary General Meeting of Shareholders on April 3, 2025, to discuss several key proposals. The agenda includes increasing the company’s authorized share capital, approving compensation terms for the Interim CEO, and granting options to board members and executives. These proposals, if approved, could significantly impact the company’s governance and capital structure, potentially influencing its market position and stakeholder interests.
More about PainReform
PainReform Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of reformulated pain therapeutics. The company aims to enhance the efficacy and safety of existing pain medications through its proprietary reformulation technologies.
YTD Price Performance: -1.54%
Average Trading Volume: 3,611,344
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.79M
For a thorough assessment of PRFX stock, go to TipRanks’ Stock Analysis page.